Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on April 12, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Affirm Holdings, Inc. - AFRM
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Daktronics, Inc. - DAKT
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Methanex Corporation - MEOH
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Methanex Corporation (“Methanex” or the “Company”) (NASDAQ: MEOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Robinhood Markets, Inc. - HOOD
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Robinhood Markets, Inc. (“Robinhood” or the “Company”) (NASDAQ: HOOD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gorilla Technology Group, Inc. - GRRR
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gorilla Technology Group, Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR). Such investors are advised to contact Danielle Peyton at newaction@ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Horizon Technology Finance Corporation - HRZN
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Horizon Technology Finance Corporation (“Horizon” or the “Company”) (NASDAQ: HRZN). Such investors are advised to contact Danielle Peyton at …
ROSEN, SKILLED INVESTOR COUNSEL, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EU
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of enCore Energy Corp. (NASDAQ: EU) between March 28, 2024 and March 2, 2025, both dates inclusive (the “Class Period”), …
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fluence Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLNC
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fluence Energy, Inc. (NASDAQ: FLNC) between November 29, 2023 and February 10, 2025, both dates inclusive (the “Class …
רוזן, משרד עורכי דין מוביל לזכויות משקיעים, מעודד את משקיעי Fluence Energy, Inc להשיג ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך - FLNC
GlobeNewswire
·
April 12, 2025
ניו יורק, April 12, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את המניות הרגילות של Fluence Energy, Inc. (נאסד"ק: FLNC) בין התאריכים 29 בנובמבר 2023 עד 10 בפברואר 2025, …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN
GlobeNewswire
·
April 12, 2025
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Geron Corporation (NASDAQ: GERN) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class …
Vantage Biosciences 完成口服 VX-01 治疗非增殖性糖尿病视网膜病变第 2 期临床研究首例患者的给药
GlobeNewswire
·
April 12, 2025
伦敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences，一家推进糖尿病眼疾创新治疗的临床阶段生物技术公司，于今日宣布已在评估 VX-01 的第 2 期临床研究中成功完成首例患者的给药，VX-01 是治疗非增殖性糖尿病视网膜病变 (NPDR) 的一种口服疗法。 糖尿病视网膜病变影响全球超 1 亿人，也是劳动年龄段成人失明的主要诱因之一。 若未及时干预，NPDR 可能发展到糖尿病眼疾的更严重阶段，从而增加视力丧失的风险。 该里程碑标志着 VX-01 …
Vantage Biosciences 的口服藥 VX-01 用於治療非增生性糖尿病視網膜病變，在其第 2 期臨床研究中，首次安排患者完成服藥
GlobeNewswire
·
April 12, 2025
倫敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences 是一間臨床階段生物科技公司，致力開發治療糖尿病眼疾的創新療法。該公司今天宣布，在其評估 VX-01 的第 2 期臨床研究中，首次安排患者成功服藥。VX-01 是一種用於治療非增生性糖尿病視網膜病變 (NPDR) 的口服藥。 糖尿病視網膜病變影響全球逾 1 億人，是就業年齡成人失明的主要原因之一。 如果不及時介入，NPDR 可能會導致糖尿病眼疾的情況變得更加嚴重，增加視力受損的風險。 …
Volektra Raises Capital to Commercialize Virtual Magnet Motor for Mobility, Industry, and Defense
GlobeNewswire
·
April 12, 2025
SACRAMENTO, Calif., April 12, 2025 (GLOBE NEWSWIRE) -- Electric drivetrain innovator Volektra has secured a new funding round to commercialize its proprietary Virtual Magnet motor technology—an industry-first breakthrough that eliminates rare earth magnets …
CROWDSTRIKE ALERT: Bragar Eagel & Squire, P.C. is Investigating CrowdStrike Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
April 12, 2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
MONOLITHIC POWER SYSTEMS ALERT: Bragar Eagel & Squire, P.C. is Investigating Monolithic Power Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
April 12, 2025
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
GlobeNewswire
·
April 12, 2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or the “Company”) announces today that it has terminated …